Provided by Tiger Fintech (Singapore) Pte. Ltd.

Edgewise Therapeutics, Inc.

13.03
+0.02000.15%
Post-market: 12.95-0.0800-0.61%16:10 EDT
Volume:361.18K
Turnover:4.70M
Market Cap:1.37B
PE:-8.41
High:13.22
Open:13.11
Low:12.86
Close:13.01
Loading ...

Edgewise Therapeutics reports Q1 EPS (43c), consensus (42c)

TIPRANKS
·
08 May

BRIEF-Edgewise Therapeutics Q1 Operating Expenses USD 45.959 Million

Reuters
·
08 May

Edgewise Therapeutics Q1 Net Income USD -40.798 Million

THOMSON REUTERS
·
08 May

Edgewise Therapeutics Q1 Operating Expenses USD 45.959 Million

THOMSON REUTERS
·
08 May

Edgewise Therapeutics Inc. Chief Scientific Officer Russell Alan J Reports Disposal of Common Shares

Reuters
·
08 May

John R. Moore, General Counsel, Reports Disposal of Edgewise Therapeutics Inc. Common Shares

Reuters
·
08 May

Why Edgewise Therapeutics Stock Popped This Week

Motley Fool
·
03 May

Guggenheim Starts Edgewise Therapeutics With Buy Rating, $41 Price Target

MT Newswires Live
·
30 Apr

Guggenheim starts Edgewise with Buy on ‘compelling entry point’

TIPRANKS
·
30 Apr

Biotech Stock Roundup: PCRX Up on Patent News, EWTX Down on Study Data & More

Zacks
·
10 Apr

Edgewise Therapeutics (EWTX): Among Unstoppable Stocks That Could Double Your Money

Insider Monkey
·
06 Apr

Major Stake Acquisitions Signal Confidence in Edgewise Therapeutics

TIPRANKS
·
05 Apr

Edgewise Therapeutics Downgraded Following Safety Issues in Heart Drug Trial

GuruFocus.com
·
04 Apr

Edgewise Therapeutics Says Believes Atrial Fibrillation Not Driven by EDG-7500 in Phase 2 Trial, RBC Says

MT Newswires Live
·
04 Apr

Edgewise Therapeutics Cut to Sector Perform From Sector Outperform by Scotiabank

Dow Jones
·
03 Apr

RBC Lowers Price Target on Edgewise Therapeutics to $52 From $56, Keeps Outperform, Speculative Risk

MT Newswires Live
·
03 Apr

U.S. RESEARCH ROUNDUP-Alphabet, Amazon, Meta

Reuters
·
03 Apr

Edgewise Therapeutics Is Maintained at Overweight by Piper Sandler

Dow Jones
·
03 Apr

BUZZ-U.S. STOCKS ON THE MOVE-M-tron, Rocket Companies, TKO Group

Reuters
·
03 Apr

BUZZ-Edgewise falls on safety, efficacy doubts for heart disease drug

Reuters
·
02 Apr